ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia

Wu, Huanyu; Sun, Xinyi; Jiang, Hongyan; Hu, Cong; Xu, Jiaxu; Sun, Changhao; Wei, Wei*; Han, Tianshu*; Jiang, Wenbo*哈尔滨医科大学; 1
Frontiers in Cardiovascular Medicine2022-7-18DOI: 10.3389/fcvm.2022.930135
8阅读
引用收藏
分享

摘要

BackgroundAcrylamide is a common environmental volatile organic compound that humans are frequently exposed to in their daily lives. However, whether exposure to acrylamide is associated with long-term survival in patients with hyperglycemia remains largely unknown. Methods and ResultsA total of 3,601 hyperglycemic people were recruited in this study, including 1,247 people with diabetes and 2,354 people with pre-diabetes, who enrolled in the National Health and Nutrition Examination survey (2003-2004, 2005-2006, and 2013-2014). The acrylamide exposure was measured by the serum hemoglobin adduct of acrylamide (HbAA) and glycidamide (HbGA), and the ratio of HbAA and HbGA (HbAA/HbGA) was calculated, which were all categorized into quintiles. The National Death Index was used to identify the participants' death information until 2015. Cox proportional hazards (CPHs) regression models were performed to examine the survival relationship between these biomarkers and mortality. During the 28,652 person-year follow-up, 268 deaths due to the cardiovascular disease (CVD) were documented. After adjustment for multiple confounders, compared with participants in the lowest quintile of HbAA/HbGA, the participants in the highest quintile were more likely to die due to CVD (hazard ratio [HR] = 1.61, 95% CI: 1.09-2.39) and all-cause (HR = 1.59, 95% CI: 1.25-2.01). Moreover, subgroup analysis showed that the highest quintile of HbAA/HbGA in the people with diabetes or pre-diabetes was related to mortalities risk of CVD (HRdiabetes = 1.92, 95% CI: 1.11-3.31; HRpre-diabetes = 1.78, 95% CI: 1.01-3.14) and all-cause mortality (HRdiabetes = 1.81, 95% CI: 1.27-2.58; HRpre-diabetes = 1.59, 95% CI: 1.14-2.20). Additionally, no significant association between the levels of HbAA or HbGA and CVD mortality was observed among people with diabetes or pre-diabetes. ConclusionHigher levels of HbAA/HbGA are associated with greater mortalities of CVD and all-cause among hyperglycemic people.

学科与关键词

关键词
CVD mortalityall-cause mortalityhyperglycemiaNHANESacrylamide
相关
加载中…
  • The association between biomarkers of acrylamide and cancer mortality in US adult population: Evidence from NHANES 2003-2014
    Gu, Wenbo; Zhang, Jiacheng; Ren, Chunling; Gao, Yang; Zhang, Tongfang; Long, Yujia; Wei, Wei; Hou, Shaoying; Sun, Changhao; Wang, Changhong*; Jiang, Wenbo*; Zhao, Junfei*Frontiers in Oncology, 2022, 12: 970021.
  • A systematic review: on the mercaptoacid metabolites of acrylamide, N-acetyl-S-(2-carbamoylethyl)-L-cysteine
    Zhao, Fang-Fang; Wang, Xiao-Li; Lei, Ya-Ting; Li, Hong-Qiu; Li, Zhi-Ming; Hao, Xiao-Xiao; Ma, Wei-Wei; Wu, Yong-Hui; Wang, Sheng-Yuan*Environmental Science and Pollution Research, 2023, 30(38): 88350-88365.
  • Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study
    Wei, Wen; Liang, Yan; Guo, Dachuan; Xu, Xinghao; Xu, Qingbo; Li, Shanggang; Li, Yuqi; Liu, Jin; Liu, Yong; Tu, Mei; Chen, Kaihong*; Chen, Hong*; Chen, Shiqun*Diabetes Research and Clinical Practice, 2022, 191: 110053.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2022-07-18
卷期
第 9 卷
页码
930135
DOI
10.3389/fcvm.2022.930135
期刊等级
3区
成果收录
SCIE
资助标注
HMU Marshal Initiative Funding [HMUMIF-21011, HMUMIF-21013]; National Natural Science Foundation of China [81803227]

作者

  • W

    Wu, Huanyu (第一作者)

    harbin med univ

  • S

    Sun, Xinyi

    harbin med univ

查看全部 9 位作者收起作者
  • J

    Jiang, Hongyan

    harbin med univ

  • H

    Hu, Cong

    harbin med univ

  • X

    Xu, Jiaxu

    harbin med univ

  • S

    Sun, Changhao

    harbin med univ

  • W

    Wei, Wei (通讯)

    harbin med univ

  • H

    Han, Tianshu (通讯)

    harbin med univ

  • J

    Jiang, Wenbo (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417